ArticleHeadache2026

Evaluation of the effectiveness and safety of anti-CGRP monoclonal antibodies in patients with migraine and autoimmune diseases: IMMUNO-CGRP study.

María Clara García-Castillo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.